Top of page

Yang Chu


A trusted adviser with a broad corporate practice, spanning ECM and DCM, public and private M&A, and corporate governance, particularly for HKEX-listed companies.

Yang has deep experience representing leading issuers and investment banks in capital market transactions, with a focus on IPOs, including headline-making first HKEX deals for pre-revenue biotech companies, dual-class share structures, SPAC listings and secondary listings. After the IPO, Yang is a trusted adviser to HKEX-listed companies on complex disclosure, compliance and corporate governance issues.

His experience in debt capital markets covers the spectrum, from high-yield and credit-enhanced bond offerings and private placements to multi-billion-dollar debt programmes for China’s leading corporates.

Yang also advises leading Chinese corporates and global PE funds on cross-border investments and acquisitions, including Hong Kong public takeovers. He is the co-author of the Hong Kong chapter of Getting the Deal Through: Private M&A.

A client quoted by Chambers says Yang is “highly capable and experienced as an individual, especially when dealing with complicated transactions.”

Experience highlights

View all experience




Chambers Greater China Region – Capital Markets: Equity (International Firms), China, Up and Coming

IFLR1000 – Capital Markets: Equity, China, Rising Star Partner

China Business Law Journal – “The A-List,” 2021

LL.B., Law, London School of Economics and Political Science
Professional history
  • Partner, 2019-present
  • Counsel, 2017-2019
  • Associate, Davis Polk, 2011-2017
  • Slaughter and May, 2007-2011
Qualifications and admissions
  • England and Wales
  • Hong Kong
Back to top